Literature DB >> 25304960

Construct validity of SF-6D health state utility values in an employed population.

Siyan Baxter1, Kristy Sanderson, Alison Venn, Petr Otahal, Andrew J Palmer.   

Abstract

BACKGROUND: Health utility values permit cost utility analysis in workplace health promotion; however, utility measures of working populations have not been validated. AIM: To investigate construct validity of SF-6D health utility in a public service workforce.
METHODS: SF-12v2 Health Survey was administered to 3,408 randomly selected public service employees in Australia in 2010. SF-12 scores were converted to SF-6D health utility values. Associations and correlates of SF-6D with health, socio-demographic and work characteristics [comorbidities, body mass index (BMI), Kessler-10 psychological distress (K10), education, salary, effort-reward imbalance (ERI), absenteeism] were explored. Ceiling effects were analysed. Nationally representative employee SF-6D values from the Household, Income and Labour Dynamics in Australia (HILDA) survey (n = 11,234) were compared. All analyses were stratified by sex.
RESULTS: Mean (SE) age was 45.7 (0.35) males; 44.5 (0.22) females. Females represented 72 % of the sample. Mean (SE) health utility 0.792 (0.004); 0.771 (0.003) was higher in males. SF-6D demonstrated both a significant inverse association (p < 0.01) and negative correlations (female; male) with K10 (r = -0.63; r = -0.66), comorbidity count (r = -0.40; r = -0.33), ERI (r = -0.37; r = -0.34) and absenteeism (p < 0.005, r = -0.25; r = -0.21). Mean (SE) SF-6D in HILDA was 0.792 (0.002); 0.775 (0.003) males; females. Correlates and associations in all samples were similar. The general employed demonstrated a significant inverse association with age and positive association with salary. SF-6D was independent of BMI.
CONCLUSIONS: Psychological distress, comorbidity, effort-reward imbalance and absenteeism are negatively associated with employee health. SF-6D is a valid measure of perceived health states in working populations.

Mesh:

Year:  2014        PMID: 25304960     DOI: 10.1007/s11136-014-0823-4

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  43 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  The use of weights to account for non-response and drop-out.

Authors:  Michael Höfler; Hildegard Pfister; Roselind Lieb; Hans-Ulrich Wittchen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-04       Impact factor: 4.328

3.  The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity.

Authors:  Maria Hagströmer; Pekka Oja; Michael Sjöström
Journal:  Public Health Nutr       Date:  2006-09       Impact factor: 4.022

4.  Reliability, validity, and minimally important differences of the SF-6D in systemic sclerosis.

Authors:  Dinesh Khanna; Daniel E Furst; Weng Kee Wong; Joel Tsevat; Philip J Clements; Grace S Park; Arnold E Postlethwaite; Mansoor Ahmed; Shaari Ginsburg; Ron D Hays
Journal:  Qual Life Res       Date:  2007-04-03       Impact factor: 4.147

5.  Causal inference in occupational epidemiology: accounting for the healthy worker effect by using structural nested models.

Authors:  Ashley I Naimi; David B Richardson; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2013-09-27       Impact factor: 4.897

6.  Adverse psychosocial working conditions and poor quality of life among financial service employees in Brazil.

Authors:  Luiz Sergio Silva; Sandhi Maria Barreto
Journal:  J Occup Health       Date:  2012-01-31       Impact factor: 2.708

7.  A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years.

Authors:  Garry R Barton; Tracey H Sach; Anthony J Avery; Claire Jenkinson; Michael Doherty; David K Whynes; Kenneth R Muir
Journal:  Health Econ       Date:  2008-07       Impact factor: 3.046

8.  US norms for six generic health-related quality-of-life indexes from the National Health Measurement study.

Authors:  Dennis G Fryback; Nancy Cross Dunham; Mari Palta; Janel Hanmer; Jennifer Buechner; Dasha Cherepanov; Shani A Herrington; Ron D Hays; Robert M Kaplan; Theodore G Ganiats; David Feeny; Paul Kind
Journal:  Med Care       Date:  2007-12       Impact factor: 2.983

9.  Testing a workplace physical activity intervention: a cluster randomized controlled trial.

Authors:  Rosemary R C McEachan; Rebecca J Lawton; Cath Jackson; Mark Conner; David M Meads; Robert M West
Journal:  Int J Behav Nutr Phys Act       Date:  2011-04-11       Impact factor: 6.457

10.  Domains of quality of life: results of a three-stage Delphi consensus procedure among patients, family of patients, clinicians, scientists and the general public.

Authors:  Suzanne Pietersma; Marieke de Vries; M Elske van den Akker-van Marle
Journal:  Qual Life Res       Date:  2013-11-17       Impact factor: 4.147

View more
  3 in total

1.  The relationship between SF-6D utility scores and lifestyle factors across three life stages: evidence from the Australian Longitudinal Study on Women's Health.

Authors:  Jeeva Kanesarajah; Michael Waller; Jennifer A Whitty; Gita D Mishra
Journal:  Qual Life Res       Date:  2017-02-03       Impact factor: 4.147

2.  An Exploratory Study: A Head-to-Head Comparison of the EQ-5D-5L and AQoL-8D for Long-Term Publicly Waitlisted Bariatric Surgery Patients Before and 3 Months After Bariatric Surgery.

Authors:  Julie A Campbell; Martin Hensher; Amanda Neil; Alison Venn; Petr Otahal; Stephen Wilkinson; Andrew J Palmer
Journal:  Pharmacoecon Open       Date:  2018-12

3.  Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.

Authors:  Admassu N Lamu; Lars Björkman; Harald J Hamre; Terje Alræk; Frauke Musial; Bjarne Robberstad
Journal:  Health Qual Life Outcomes       Date:  2021-04-17       Impact factor: 3.186

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.